In pursuit of virtual lead optimization: Pruning ensembles of receptor structures for increased efficiency and accuracy during docking

被引:30
作者
Bolstad, Erin S. D. [1 ]
Anderson, Amy C. [1 ]
机构
[1] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA
基金
美国国家科学基金会;
关键词
docking; DHFR; crystal structure; solution structure; homology models; ensembles; protein flexibility; CASEI DIHYDROFOLATE-REDUCTASE; RESOLUTION CRYSTAL-STRUCTURES; PROTEIN-LIGAND INTERACTIONS; HIV-1; PROTEASE; ESCHERICHIA-COLI; LACTOBACILLUS-CASEI; MOLECULAR-DYNAMICS; DRUG-RESISTANCE; ANTIFOLATE RESISTANCE; THYMIDYLATE SYNTHASE;
D O I
10.1002/prot.22214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Representing receptors as ensembles of protein conformations during docking is a powerful method to approximate protein flexibility and increase the accuracy of the resulting ranked list of compounds. Unfortunately, docking compounds against a large number of ensemble members can increase computational cost and time investment. In this article, we present an efficient method to evaluate and select the most contributive ensemble members prior to docking for targets with a conserved core of residues that bind a ligand moiety. We observed that ensemble members that preserve the geometry of the active site core are most likely to place ligands in the active site with a conserved orientation, generally rank ligands correctly and increase interactions with the receptor. A relative distance approach is used to quantify the preservation of the three-dimensional interatomic distances of the conserved ligand-binding atoms and prune large ensembles quickly. in this study, we investigate dihydrofolate reductase as an example of a protein with a conserved core; however, this method for accurately selecting relevant ensemble members a priori can be applied to any system with a conserved ligand-binding core, including HIV-1 protease, kinases, and acetylcholinesterase. Representing a drug target as a pruned ensemble during in silico, screening should increase the accuracy and efficiency of high-throughput analyses of lead analogs.
引用
收藏
页码:62 / 74
页数:13
相关论文
共 64 条
[1]
Combining docking and molecular dynamic simulations in drug design [J].
Alonso, Hernan ;
Bliznyuk, Andrey A. ;
Gready, Jill E. .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (05) :531-568
[2]
AMARO RE, J COMPUT AI IN PRESS
[3]
Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance [J].
Anderson, AC .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2005, 61 :258-262
[4]
[Anonymous], 2007, SYBYL 7 3
[5]
Neutron diffraction studies of Escherichia coli dihydrofolate reductase complexed with methotrexate [J].
Bennett, Brad ;
Langan, Paul ;
Coates, Leighton ;
Mustyakimov, Marat ;
Schoenborn, Benno ;
Howell, Elizabeth E. ;
Dealwis, Chris .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (49) :18493-18498
[6]
Berndt KD, 1996, PROTEINS, V24, P304
[7]
BOLIN JT, 1982, J BIOL CHEM, V257, P13650
[8]
In pursuit of virtual lead optimization: The role of the receptor structure and ensembles in accurate docking [J].
Bolstad, Erin S. D. ;
Anderson, Amy C. .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 73 (03) :566-580
[9]
Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models [J].
Bowman, Anna L. ;
Nikolovska-Coleska, Zaneta ;
Zhong, Haizhen ;
Wang, Shaomeng ;
Carlson, Heather A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (42) :12809-12814
[10]
Protein flexibility and species specificity in structure-based drug discovery: Dihydrofolate reductase as a test system [J].
Bowman, Anna L. ;
Lerner, Michael G. ;
Carlson, Heather A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (12) :3634-3640